These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19860865)

  • 1. Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease.
    Pineda JR; Pardo R; Zala D; Yu H; Humbert S; Saudou F
    Mol Brain; 2009 Oct; 2():33. PubMed ID: 19860865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421.
    Pardo R; Colin E; Régulier E; Aebischer P; Déglon N; Humbert S; Saudou F
    J Neurosci; 2006 Feb; 26(5):1635-45. PubMed ID: 16452687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies.
    Brito V; Puigdellívol M; Giralt A; del Toro D; Alberch J; Ginés S
    Cell Death Dis; 2013 Apr; 4(4):e595. PubMed ID: 23598407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Huntington's disease: intracellular signaling pathways and neuronal death].
    Humbert S; Saudou F
    J Soc Biol; 2005; 199(3):247-51. PubMed ID: 16471265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons.
    Zala D; Colin E; Rangone H; Liot G; Humbert S; Saudou F
    Hum Mol Genet; 2008 Dec; 17(24):3837-46. PubMed ID: 18772195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early down-regulation of PKCδ as a pro-survival mechanism in Huntington's disease.
    Rué L; Alcalá-Vida R; López-Soop G; Creus-Muncunill J; Alberch J; Pérez-Navarro E
    Neuromolecular Med; 2014 Mar; 16(1):25-37. PubMed ID: 23896721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells.
    Xifró X; García-Martínez JM; Del Toro D; Alberch J; Pérez-Navarro E
    J Neurochem; 2008 Jun; 105(5):1596-612. PubMed ID: 18221365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice.
    Lloret A; Dragileva E; Teed A; Espinola J; Fossale E; Gillis T; Lopez E; Myers RH; MacDonald ME; Wheeler VC
    Hum Mol Genet; 2006 Jun; 15(12):2015-24. PubMed ID: 16687439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites.
    Liot G; Zala D; Pla P; Mottet G; Piel M; Saudou F
    J Neurosci; 2013 Apr; 33(15):6298-309. PubMed ID: 23575829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity.
    Xifró X; Giralt A; Saavedra A; García-Martínez JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E
    Neurobiol Dis; 2009 Dec; 36(3):461-9. PubMed ID: 19733666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulator of calcineurin (RCAN1-1L) is deficient in Huntington disease and protective against mutant huntingtin toxicity in vitro.
    Ermak G; Hench KJ; Chang KT; Sachdev S; Davies KJ
    J Biol Chem; 2009 May; 284(18):11845-53. PubMed ID: 19270310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
    Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J
    Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death.
    Conforti P; Camnasio S; Mutti C; Valenza M; Thompson M; Fossale E; Zeitlin S; MacDonald ME; Zuccato C; Cattaneo E
    Neurobiol Dis; 2013 Feb; 50():160-70. PubMed ID: 23089356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced sensitivity of striatal neurons to axonal transport defects induced by mutant huntingtin.
    Her LS; Goldstein LS
    J Neurosci; 2008 Dec; 28(50):13662-72. PubMed ID: 19074039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice.
    Gharami K; Xie Y; An JJ; Tonegawa S; Xu B
    J Neurochem; 2008 Apr; 105(2):369-79. PubMed ID: 18086127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology.
    Choudhury KR; Das S; Bhattacharyya NP
    J Proteomics; 2016 Jan; 132():155-66. PubMed ID: 26581643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain.
    Fusco FR; Zuccato C; Tartari M; Martorana A; De March Z; Giampà C; Cattaneo E; Bernardi G
    Eur J Neurosci; 2003 Sep; 18(5):1093-102. PubMed ID: 12956709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity.
    Xifró X; Anglada-Huguet M; Rué L; Saavedra A; Pérez-Navarro E; Alberch J
    Mol Neurodegener; 2011 Oct; 6():74. PubMed ID: 22041125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
    Zuccato C; Ciammola A; Rigamonti D; Leavitt BR; Goffredo D; Conti L; MacDonald ME; Friedlander RM; Silani V; Hayden MR; Timmusk T; Sipione S; Cattaneo E
    Science; 2001 Jul; 293(5529):493-8. PubMed ID: 11408619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.
    Saavedra A; García-Martínez JM; Xifró X; Giralt A; Torres-Peraza JF; Canals JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E
    Cell Death Differ; 2010 Feb; 17(2):324-35. PubMed ID: 19745829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.